Please login to the form below

Not currently logged in
Email:
Password:

Scott Gottlieb

This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.

COVID-19 vaccines against Omicron may be fast-tracked

COVID-19 vaccines against Omicron may be fast-tracked

Scott Gottlieb, now working at Pfizer but previously commissioner of the US FDA agreed, saying there was “a reasonable degree of confidence in vaccine circles that [with] at least three ... Gottlieb agreed, saying the FDA was familiar with the mRNA

Latest news

More from news
Approximately 5 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    He replaced Scott Gottlieb, who was popular with industry but resigned from the post unexpectedly last year, as well as stand-in Ned Sharpless who has now returned to his post

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    In the early days of the Trump administration, then-FDA commissioner Scott Gottlieb made a point of clearing the way for even faster and more generic approvals, again with some apparent ... Based on those assumed savings, had all the FDA-approved

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    The timing of the withdrawal was ironic given that, in the same month, FDA Commissioner Scott Gottlieb highlighted ‘TMB as a potential biomarker for enriching clinical trials testing immunotherapies’. ... Harmonisation. Gottlieb has since resigned,

  • Streamlining clinical trials – why better data use is key Streamlining clinical trials – why better data use is key

    Dr Scott Gottlieb’s brief, energetic tenure as US FDA Commissioner is likely to shape agency oversight of the pharmaceutical industry for years to come, particularly in relation to clinical development. ... To embrace innovations like blockchain, as

  • Cell and gene therapy Cell and gene therapy

    Interest in cell and gene therapies is undeniable. In January, US FDA Commissioner Scott Gottlieb outlined policies designed to accommodate an anticipated surge in cell and gene therapy submissions. ... Gottlieb highlighted manufacture as a challenge

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....